티앤엘 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 최윤소, was filed 10 Aug 2026.
티앤엘: what insiders have been doing
티앤엘 is a Health Care company. Its directors and officers file their transactions with DART (FSS). 8 insiders have disclosed 18 filings since 2 November 2025.
On the market, 8 insiders bought (14 purchases) while 1 insider sold (2 sales). No amount is published for 16 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 7 board members and 1 chief executive.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 18 filings, this issuer sits above that mark. The full history, which starts in 2021, counts 14 purchases against 11 sales.
The most recent open-market purchase was published on 10 August 2026, 92 days ago. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+2 other insiders
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 37,680 sharesShareKRXDART:20260810000164Canonical exit: 8 Nov 2026 (T+90)
- 60,000 sharesShareKRXDART:20260810000166Canonical exit: 8 Nov 2026 (T+90)
- 14,000 sharesShareKRXDART:20260810000146Canonical exit: 8 Nov 2026 (T+90)
- 196,460 sharesShareKRXDART:20260810000169Canonical exit: 8 Nov 2026 (T+90)
- 1,926,000 sharesShareKRXDART:20260810000173Canonical exit: 8 Nov 2026 (T+90)
- 912,520 sharesShareKRXDART:20260810000171Canonical exit: 8 Nov 2026 (T+90)
- 35,200 sharesShareKRXDART:20260810000156Canonical exit: 8 Nov 2026 (T+90)
- 18,610 sharesShareKRXDART:20260810000151Canonical exit: 8 Nov 2026 (T+90)
- 200,000 sharesKRXDART:20260611000662
- 0KRXDART:20260408003466
- 6,870 sharesKRXDART:20260102000452Canonical exit: 31 Mar 2026 (T+90)
- 60,000 sharesShareKRXDART:20260102000418Canonical exit: 2 Apr 2026 (T+90)
- 912,520 sharesShareKRXDART:20260102000401Canonical exit: 2 Apr 2026 (T+90)
- 850,000 sharesShareKRXDART:20260102000304
- 1,210 sharesShareKRXDART:20251224000626Canonical exit: 24 Mar 2026 (T+90)
- 1,680 sharesShareKRXDART:20251224000606Canonical exit: 24 Mar 2026 (T+90)
- 1,460 sharesShareKRXDART:20251224000617Canonical exit: 24 Mar 2026 (T+90)
- ●Executives0DART
- 86,000 sharesKRXDART:20240522000441
- ShareKRXDART:20240522000438
- ShareKRXDART:20240522000434
- ShareKRXDART:20231213000381
- ShareKRXDART:20230616000434
- 40,000 sharesShareKRXDART:20230112000339
- 3,800 sharesKRXDART:20220324000758
25 of 54 declarations
About 티앤엘
티앤엘 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
